Strategic Growth Position BASi as a case study for expanded nonclinical services and integrated instrument manufacturing capabilities to Pharmaceutical clients seeking end-to-end development support, highlighting potential upsell from contract research to instrument supply.

Operating Leadership Leverage recent leadership hires in operations, pathology, and HR to identify clients prioritizing scalable CRO partnerships and robust project governance, offering value through enhanced program management and global delivery capabilities.

Clinical Pipeline Target mid to large pharma with BASi’s nonclinical and analytical CRO strengths to win expanded testing across DMPK, pathology, and surgical models, aligning service offerings with stages of drug development to capture larger project scopes.

Cost and Efficiency Emphasize BASi’s goal of reducing time to market and costs, presenting solutions that combine CRO services with instrument availability to shorten procurement cycles for customers requiring rapid instrumentation access.

Strategic Partnerships Explore acquisitions or asset repositioning opportunities (as evidenced by past asset purchases) to broaden capabilities and cross-sell integrated services to existing BASi clients and new biotech firms seeking comprehensive research ecosystems.